Prothena Corporation plc (NASDAQ: PRTA) kicked off on Tuesday, up 2.58% from the previous trading day, before settling in for the closing price of $9.30. Over the past 52 weeks, PRTA has traded in a range of $9.00-$25.42.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 4692.68% over the past five years. While this was happening, its average annual earnings per share was recorded -58.69%. With a float of $42.50 million, this company’s outstanding shares have now reached $53.83 million.
Let’s look at the performance matrix of the company that is accounted for 163 employees. In terms of profitability, gross margin is 56.79%, operating margin of -114.36%, and the pretax margin is -95.39%.
Prothena Corporation plc (PRTA) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Prothena Corporation plc is 21.05%, while institutional ownership is 98.22%.
Prothena Corporation plc (PRTA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.87 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -58.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -15.39% during the next five years compared to -3.15% drop over the previous five years of trading.
Prothena Corporation plc (NASDAQ: PRTA) Trading Performance Indicators
Take a look at Prothena Corporation plc’s (PRTA) current performance indicators. Last quarter, stock had a quick ratio of 10.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.30, a number that is poised to hit -0.97 in the next quarter and is forecasted to reach -3.53 in one year’s time.
Technical Analysis of Prothena Corporation plc (PRTA)
Prothena Corporation plc (NASDAQ: PRTA) saw its 5-day average volume 0.62 million, a positive change from its year-to-date volume of 0.46 million. As of the previous 9 days, the stock’s Stochastic %D was 15.44%. Additionally, its Average True Range was 0.81.
During the past 100 days, Prothena Corporation plc’s (PRTA) raw stochastic average was set at 6.24%, which indicates a significant decrease from 16.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.59% in the past 14 days, which was lower than the 83.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.94, while its 200-day Moving Average is $16.64. Nevertheless, the first resistance level for the watch stands at $9.72 in the near term. At $9.91, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.16. If the price goes on to break the first support level at $9.28, it is likely to go to the next support level at $9.03. The third support level lies at $8.84 if the price breaches the second support level.
Prothena Corporation plc (NASDAQ: PRTA) Key Stats
The company with the Market Capitalisation of 513.51 million has total of 53,827K Shares Outstanding. Its annual sales at the moment are 135,160 K in contrast with the sum of -122,310 K annual income. Company’s last quarter sales were recorded 2,120 K and last quarter income was -57,960 K.
